tradingkey.logo

Novocure Says Ttfields Therapy Shows Significant Improvement In Overall Survival For Pancreatic Cancer

ReutersMay 31, 2025 12:07 PM

- Novocure Ltd NVCR.O:

  • RESULTS FROM THE PHASE 3 PANOVA-3 TRIAL OF NOVOCURE’S TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PANCREATIC CANCER TO BE PRESENTED AT 2025 ASCO ANNUAL MEETING

  • NOVOCURE LTD - TTFIELDS THERAPY SHOWS SIGNIFICANT IMPROVEMENT IN OVERALL SURVIVAL FOR PANCREATIC CANCER

  • NOVOCURE LTD - TO FILE FOR FDA APPROVAL OF TTFIELDS THERAPY IN H2 2025

  • NOVOCURE LTD - PANOVA-3 TRIAL MEETS PRIMARY ENDPOINT WITH SIGNIFICANT IMPROVEMENT IN MEDIAN OS

  • NOVOCURE LTD - TTFIELDS THERAPY IMPROVES ONE-YEAR SURVIVAL RATE TO 68.1%

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI